Fed pause left markets largely flat

February 17, 2026 at 21:00 UTC

5 min read
Fed and ECB policy impact on U.S. benchmarks and European stocks, steady yields, market reaction

Key Points

  • Fed speakers emphasized a data-dependent pause, keeping Treasury yields broadly stable.
  • ECB announcements reinforced supervisory continuity and influenced euro-area liquidity pricing, supporting European outperformance.
  • U.S. benchmarks finished near flat as Fed signals and steady yields offset mixed sector and corporate news.
  • Sector divergence emerged as Financials and Real Estate outperformed while Consumer Staples, Energy and Materials lagged.

Global Market Summary

U.S. benchmarks ended essentially flat as Fed officials signaled a data-dependent pause; SPX rose 0.10%, ^IXIC rose 0.10% and DJIA gained 0.06%. European indices outperformed, with DAX up 0.80%, UKX up 0.79% and FRA40 up 0.54%, supported by ECB supervisory continuity and weekly liquidity data. In Asia NKY fell 0.42%.

Top Movers

Strongest sectors: Financials (XLF +1.07%) and Real Estate (VNQ +0.94%), with Industrials (XLI +0.55%) also outperforming. Weakest sectors: Consumer Staples (XLP -1.49%), Energy (XLE -1.08%) and Materials (XLB -0.98%) lagged. Notable movers: MASI (+34.26%), ZIM (+24.82%) and ETOR (+22.00%) led gainers; FELE (-14.62%), GPC (-14.28%) and IPGP (-13.35%) were the largest decliners.

Macro highlights

Fed speakers including Chicago Fed President Goolsbee, Governor Barr and SF Fed President Daly emphasized a data-dependent pause and the need for sustained disinflation, keeping Treasury yields broadly stable and preserving expectations for later easing if progress continues. ECB announcements — an extension of Supervisory Board vice-chair Frank Elderson and a Eurosystem statement showing a EUR 11.5bn rise in base money and a EUR 0.8bn FX position increase — reinforced supervisory continuity and influenced short-term euro-area liquidity pricing. Regional data were mixed as the NY Fed Empire State index held at 7.1, signaling modest manufacturing expansion amid elevated input-price readings.

News that moved markets

Krystal Biotech (KRYS) reported Q4 VYJUVEK net product revenue of $107.1M, a $955.9M cash position and FDA RMAT/Fast Track designations for KB707 and KB111, factors cited as supportive for KRYS. Medtronic (MDT) posted Q3 FY26 revenue of $9.017B and non-GAAP EPS of $1.36, reiterated FY26 guidance and highlighted cardiovascular strength, which underpinned healthcare sector sentiment. Genuine Parts (GPC) missed Q4 sales and EPS, issued conservative 2026 guidance and announced a planned split that sent shares sharply lower, while Elbit Systems (ESLT) reported roughly $435M in contract awards, boosting backlog visibility.

Upcoming session watchlist

  • GB Inflation Rate YoY (Jan) — consensus 3% vs 3.4% prior, Feb 18, 07:00 AM | Signals near-term inflation trend and underlying consumer price pressures.
  • US Durable Goods Orders MoM (Dec) — forecast -3.4% vs 5.3% prior, Feb 18, 01:30 PM | Indicates manufacturing momentum and business investment demand across core goods sectors.
  • US Housing Starts (Nov) — forecast 1.27M vs 1.246M prior, Feb 18, 01:30 PM | Tracks residential construction activity and overall housing market momentum.
  • US Building Permits Prel (Dec) — forecast 1.31M, Feb 18, 01:30 PM | Leads future residential construction and the housing supply pipeline.
  • US FOMC Minutes — Feb 18, 07:00 PM | Provides insight into policy discussions and assessments of economic conditions.

Key Takeaways

  • U.S. benchmarks ended essentially flat as Fed comments kept yields steady.
  • European indices outperformed, aided by ECB supervisory continuity and a rise in base money that influenced liquidity pricing.
  • Sectors diverged: Financials and Real Estate outperformed while Consumer Staples, Energy and Materials lagged.
  • Company news drove stock moves: KRYS and MDT were cited as supportive while GPC's miss and conservative guidance sent shares sharply lower.

References

  1. 1. https://www.globenewswire.com/news-release/2026/02/17/3239069/0/en/Krystal-Biotech-Announces-Fourth-Quarter-and-Full-Year-2025-Financial-and-Operating-Results.html
  2. 2. https://www.prnewswire.com/il/news-releases/elbit-systems-awarded-contracts-valued-at-approximately-435-million-for-advanced-defense-systems-302689327.html
  3. 3. https://www.prnewswire.com/news-releases/medtronic-reports-strong-third-quarter-fiscal-2026-results-with-highest-enterprise-revenue-growth-in-10-quarters-302689151.html
  4. 4. https://portlandgeneral.com/news/2026-02-Portland-General-Electric-announces-acquisition-of-Washington-state-utility-operations-and-select-assets-from-PacifiCorp
  5. 5. https://www.genpt.com/2026-02-17-Genuine-Parts-Company-Reports-Fourth-Quarter-and-Full-Year-2025-Results
  6. 6. https://investors.danaher.com/2026-02-17-Danaher-To-Acquire-Masimo-Corporation
  7. 7. https://news.medtronic.com/2026-02-17-Medtronic-reports-strong-third-quarter-fiscal-2026-results-with-highest-enterprise-revenue-growth-in-10-quarters
  8. 8. https://www.ecb.europa.eu/press/pr/date/2026/html/ecb.pr260217~de3756e561.en.html
  9. 9. https://www.ecb.europa.eu/press/annual-reports-financial-statements/wfs/2026/html/ecb.fs260217.en.html
  10. 10. https://finance.yahoo.com/news/feds-goolsbee-several-rate-cuts-155434893.html
  11. 11. https://www.newyorkfed.org/survey/empire/empiresurvey_overview
  12. 12. https://www.reuters.com/business/feds-barr-says-central-bank-likely-hold-some-time-it-watches-easing-inflation-2026-02-17
  13. 13. https://www.reuters.com/business/feds-daly-says-us-central-bank-still-needs-get-inflation-down-2026-02-17